The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer
Highlights from ASCO 2020
An oncologist's experience of managing breast cancer during the COVID-19 outbreak
The potential of KRAS inhibitors for non-small-cell lung cancer
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer
Enhancing curative resection for GI cancers; margins, nodes and recovery
Neoadjuvant radiotherapy in rectal cancers
Management of GI cancers: Burdens, outcomes, gaps
Role of adjuvant and neoadjuvant therapy in colorectal cancer
Management of early stage stomach and colorectal cancers
Advanced stomach and colorectal cancers